arrow
R

Rodrigo Romero

Novartis
H指数:9
被引数:2,091

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
2024-10-111
OAAI
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1 (vol 1, pg 589, 2020)

Keap1突变使肺腺癌依赖于Slc33a1 (第1卷,589页,2020)

2020-08-211
OAAI
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
2020-06-0844
OAAI
Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities.
2018-05-140
PRE
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
2017-10-02486
OAAI
Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
2014-02-11355
OAAI
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma
2013-12-22308
PREAI
A functional screen of the epigenome identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers
2013-11-010
PRE